• Return to Headlines

Shares of Agile Therapeuti Rank the Lowest in Terms of Sales per Share in the Pharmaceuticals Industry (AGRX, AERI, ECYT, ITCI, RVNC)

By Shiri Gupta

Below are the three companies in the Pharmaceuticals industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Agile Therapeuti ranks lowest with a sales per share of $0.00. Following is Aerie Pharmaceut with a sales per share of $0.00. Endocyte Inc ranks third lowest with a sales per share of $0.00.

Intra-Cellular T follows with a sales per share of $0.00, and Revance Therapeu rounds out the bottom five with a sales per share of $0.01.

SmarTrend recommended that its subscribers protect gains by selling shares of Revance Therapeu on February 5th, 2018 by issuing a Downtrend alert when the shares were trading at $30.60. Since that call, shares of Revance Therapeu have fallen 13.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest sales per share agile therapeuti aerie pharmaceut endocyte inc intra-cellular t revance therapeu